All Work

Paul Ausick

What More Can Bristol-Myers Squibb Do?

Pharmaceuticals giant Bristol-Myers reported third-quarter results Thursday morning that beat analysts' expectations on both the top and bottom lines. So why did shares trade lower?

Paul Ausick · 6 years ago

Why Electric Vehicle Stocks Continue to Soar

A Citigroup analyst on Wednesday raised his price target on one Chinese EV maker's stock and started coverage on two others. Short version: he likes what he sees.

Paul Ausick · 6 years ago